Literature DB >> 10085042

Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep.

L Piacenza1, D Acosta, I Basmadjian, J P Dalton, C Carmona.   

Abstract

The potential of different parasite proteinases for use as vaccine candidates against fascioliasis in sheep was studied by vaccinating animals with the cathepsin L proteinases CL1 and CL2 and with leucine aminopeptidase (LAP) purified from adult flukes. In the first trial, sheep were immunized with CL1 or CL2 and the mean protection levels obtained were 33 and 34%, respectively. Furthermore, a significant reduction in egg output was observed in sheep vaccinated either with CL1 (71%) or with CL2 (81%). The second trial was performed to determine the protective potential of the two cathepsin L proteinases assayed together, as well as in combination with LAP, and of LAP alone. The combination of CL1 and CL2 induced higher levels of protection (60%) than those produced when these enzymes were administered separately. Those sheep that received the cocktail vaccine including CL1, CL2, and LAP were significantly protected (78%) against metacercarial challenge, but vaccination with LAP alone elicited the highest level of protection (89%). All vaccine preparations induced high immunoglobulin G titers which were boosted after the challenge infection, but no correlations between antibody titers and worm burdens were found. However, the sera of those animals vaccinated with LAP contained LAP-neutralizing antibodies. Reduced liver damage, as assessed by the level of the liver enzyme gamma-glutamyl transferase, was observed in the groups vaccinated with CL1, CL2, and LAP or with LAP alone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085042      PMCID: PMC96552          DOI: 10.1128/IAI.67.4.1954-1961.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

Review 1.  Parasite proteases.

Authors:  J H McKerrow
Journal:  Exp Parasitol       Date:  1989-01       Impact factor: 2.011

2.  Progress in development of liver fluke vaccines.

Authors:  T W Spithill; J P Dalton
Journal:  Parasitol Today       Date:  1998-12

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Adaptation of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions.

Authors:  M G Redinbaugh; R B Turley
Journal:  Anal Biochem       Date:  1986-03       Impact factor: 3.365

5.  The resistance of sheep to Fasciola hepatica: studies on the development and pathogenicity of challenge infections.

Authors:  K B Sinclair
Journal:  Br Vet J       Date:  1973 May-Jun

6.  Maturation of the head of bacteriophage T4. I. DNA packaging events.

Authors:  U K Laemmli; M Favre
Journal:  J Mol Biol       Date:  1973-11-15       Impact factor: 5.469

7.  In vivo half-life of a protein is a function of its amino-terminal residue.

Authors:  A Bachmair; D Finley; A Varshavsky
Journal:  Science       Date:  1986-10-10       Impact factor: 47.728

8.  Thiol proteases released in vitro by Fasciola hepatica.

Authors:  J P Dalton; M Heffernan
Journal:  Mol Biochem Parasitol       Date:  1989-06-15       Impact factor: 1.759

9.  Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep.

Authors:  J L Sexton; A R Milner; M Panaccio; J Waddington; G Wijffels; D Chandler; C Thompson; L Wilson; T W Spithill; G F Mitchell
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

10.  Purification and characterization of human placental microsomal aminopeptidase: immunological difference between placental microsomal aminopeptidase and pregnancy serum cystyl-aminopeptidase.

Authors:  O Kurauchi; S Mizutani; K Okano; O Narita; Y Tomoda
Journal:  Enzyme       Date:  1986
View more
  37 in total

1.  Structural and immunological characteristics of a 28-kilodalton cruzipain-like cysteine protease of Paragonimus westermani expressed in the definitive host stage.

Authors:  D H Yun; J Y Chung; Y B Chung; Y Y Bahk; S Y Kang; Y Kong; S Y Cho
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

2.  Molecular identification and characterization of leucine aminopeptidase 2, an excretory-secretory product of Clonorchis sinensis.

Authors:  Chuanhuan Deng; Jiufeng Sun; Xuerong Li; Lexun Wang; Xuchu Hu; Xiaoyun Wang; Wenjun Chen; Xiaoli Lv; Chi Liang; Wenfang Li; Yan Huang; Ran Li; Zhongdao Wu; Xinbing Yu; Jin Xu
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

3.  Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct.

Authors:  Ana M Espino; Adelaida Morales; Bonnibel Delgado; Francheska M Rivera; Olgary Figueroa; Erick Suárez
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

4.  Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii.

Authors:  Lukasz Kedzierski; Casilda G Black; Matthew W Goschnick; Anthony W Stowers; Ross L Coppel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  A deep exploration of the transcriptome and "excretory/secretory" proteome of adult Fascioloides magna.

Authors:  Cinzia Cantacessi; Jason Mulvenna; Neil D Young; Martin Kasny; Petr Horak; Ammar Aziz; Andreas Hofmann; Alex Loukas; Robin B Gasser
Journal:  Mol Cell Proteomics       Date:  2012-08-16       Impact factor: 5.911

6.  Secreted cathepsin L-like peptidases are involved in the degradation of trapped antibodies on the surface of Echinostoma caproni.

Authors:  Alba Cortés; Libor Mikeš; Carla Muñoz-Antolí; María Álvarez-Izquierdo; J Guillermo Esteban; Petr Horák; Rafael Toledo
Journal:  Parasitol Res       Date:  2019-11-12       Impact factor: 2.289

7.  Survey of transcripts expressed by the invasive juvenile stage of the liver fluke Fasciola hepatica.

Authors:  Martín Cancela; Natalia Ruétalo; Nicolás Dell'Oca; Edileuza da Silva; Pablo Smircich; Gabriel Rinaldi; Leda Roche; Carlos Carmona; Fernando Alvarez-Valín; Arnaldo Zaha; José F Tort
Journal:  BMC Genomics       Date:  2010-04-07       Impact factor: 3.969

8.  A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites.

Authors:  Simone A Beckham; David Piedrafita; Carolyn I Phillips; Nirma Samarawickrema; Ruby H P Law; Peter M Smooker; Noelene S Quinsey; James A Irving; Deanne Greenwood; Steven H L Verhelst; Matthew Bogyo; Boris Turk; Theresa H Coetzer; Lakshmi C Wijeyewickrema; Terry W Spithill; Robert N Pike
Journal:  Int J Biochem Cell Biol       Date:  2009-02-20       Impact factor: 5.085

9.  Leucine aminopeptidase is an immunodominant antigen of Fasciola hepatica excretory and secretory products in human infections.

Authors:  A Marcilla; J E De la Rubia; J Sotillo; D Bernal; C Carmona; Z Villavicencio; D Acosta; J Tort; F J Bornay; J G Esteban; R Toledo
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

10.  Characterization of cysteine proteases from the carcinogenic liver fluke, Opisthorchis viverrini.

Authors:  Natthawut Kaewpitoon; Thewarach Laha; Sasithorn Kaewkes; Puangrat Yongvanit; Paul J Brindley; Alex Loukas; Banchob Sripa
Journal:  Parasitol Res       Date:  2007-12-19       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.